Structure-based virtual screening identifies ethyl rosmarinate as a SLC1A6-targeted therapeutic candidate for bladder cancer.
Wang H, Liu H, Ma X · Frontiers in pharmacology · 2026 · Article
10.3389/fphar.2026.1895264
Verified evidence
Network node removal
10129d5f-fd10-58a6-959e-0744045dce6aPrediction source Version of record · PDF page(s) 17, 19
Study f93ed617-3d3f-5b3f-9900-fd41a6aebb53 · Prediction record (JSON)
Prediction fields
- Comparator
- baseline_or_control · PDF page(s) 19
- Reference type
- simulated_against_baseline · PDF page(s) 17, 19
- Scenario
- within_model_scenario_comparison · PDF page(s) 17, 19
Model evaluation
16a9507c-e6c9-5fca-9e84-1c6ee1fae57bPrediction source Version of record · PDF page(s) 11
Study f93ed617-3d3f-5b3f-9900-fd41a6aebb53 · Prediction record (JSON)
Prediction fields
- Endpoint
- hazard_ratio · PDF page(s) 11
- Family
- clinical_outcomes · PDF page(s) 11
- Measured variable
- survival_overall · PDF page(s) 11, 12
- Metric
- hazard_ratio · PDF page(s) 11
- Outcome target
- overall_survival · PDF page(s) 11
- Prediction target type
- future_clinical_outcome · PDF page(s) 11
- Result operation
- survival_association · PDF page(s) 11
Validation Direct comparison · Same source · Sample overlap · Indeterminate · Matched conditions · Not statistically significant